ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.
暂无分享,去创建一个
Hongyun Wang | Housheng Hansen He | X Shirley Liu | Lorelei Mucci | Sen Chen | Massimo Loda | Myles Brown | M. Loda | Myles A Brown | X. Liu | H. He | Qianben Wang | S. Balk | L. Mucci | Xin Yuan | Hongyun Wang | C. Fiore | C. Cai | Sen Chen | Lingfeng He | Fen Ma | A. Sowalsky | Qianben Wang | Changmeng Cai | Steven P Balk | Xin Yuan | Christopher Fiore | Adam G Sowalsky | Lingfeng He | Fen Ma | Adam G. Sowalsky | Myles A. Brown | X. Liu | Changmeng Cai | X. Liu
[1] M. Ittmann,et al. Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts. , 2008, Cancer research.
[2] M. Loda,et al. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] K. Pienta,et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. , 2007, Molecular cell.
[4] M. Teitell,et al. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells , 2009, Proceedings of the National Academy of Sciences.
[5] V. Vidal,et al. SOX9 expression is a general marker of basal cell carcinoma and adnexal‐related neoplasms , 2008, Journal of cutaneous pathology.
[6] N. Hanley,et al. Understanding the role of SOX9 in acquired diseases: lessons from development. , 2011, Trends in molecular medicine.
[7] T. Golub,et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. , 2006, Cancer research.
[8] R. Kist,et al. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. , 2007, Developmental biology.
[9] M. Shen,et al. Sox9 is required for prostate development. , 2008, Developmental biology.
[10] Jennifer R. Rider,et al. The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[11] P. Nelson,et al. A causal role for ERG in neoplastic transformation of prostate epithelium , 2008, Proceedings of the National Academy of Sciences.
[12] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[13] D. Tindall,et al. Androgen regulation of gene expression. , 2010, Advances in cancer research.
[14] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[15] J. Deng,et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine , 2011, Nature Genetics.
[16] R. Shah,et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.
[17] Manuel Serrano,et al. Oncogenicity of the developmental transcription factor Sox9. , 2012, Cancer research.
[18] L. Marchionni,et al. An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. , 2011, Cancer research.
[19] C. Hsiung,et al. Upregulation of SOX9 in Lung Adenocarcinoma and Its Involvement in the Regulation of Cell Growth and Tumorigenicity , 2010, Clinical Cancer Research.
[20] Hongyun Wang,et al. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. , 2008, Cancer research.
[21] A. Malek,et al. ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer , 2010, PloS one.
[22] J. Cuzick,et al. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. , 2010, Cancer research.
[23] Pier Paolo Pandolfi,et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate , 2009, Nature Genetics.
[24] R. Teasdale,et al. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. , 2002, Developmental cell.
[25] R. Kist,et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool , 2007, Proceedings of the National Academy of Sciences.
[26] O. Kallioniemi,et al. FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. , 2010, Cancer research.
[27] L. Hennighausen,et al. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV‐LTR and the tetracycline responsive system , 1995, Journal of Cellular Biochemistry.
[28] Sahar Mansour,et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.
[29] A. Chinnaiyan,et al. Recurrent gene fusions in prostate cancer , 2008, Nature Reviews Cancer.
[30] G Parmigiani,et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer , 2008, Oncogene.
[31] Leif E. Peterson,et al. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. , 2007, Cancer cell.
[32] L. Marchionni,et al. Sox9 is required for prostate development and prostate cancer initiation , 2012, Oncotarget.
[33] Clifford A. Meyer,et al. Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer , 2009, Cell.
[34] C. Sander,et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis , 2009, Nature Genetics.
[35] M. Lai,et al. Analysis of SOX9 expression in colorectal cancer. , 2008, American journal of clinical pathology.
[36] P. Nelson,et al. Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. , 2011, Cancer cell.
[37] J. Ortonne,et al. Sox9 Is Essential for Outer Root Sheath Differentiation and the Formation of the Hair Stem Cell Compartment , 2005, Current Biology.
[38] Wenjun Guo,et al. Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.
[39] S. Balk,et al. Reactivation of androgen receptor-regulated TMPRSS2:ERG gene expression in castration-resistant prostate cancer. , 2009, Cancer research.
[40] Tao Zhang,et al. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. , 2007, Cancer research.
[41] Hans Clevers,et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes , 2004, The Journal of cell biology.
[42] Carlos Cordon-Cardo,et al. Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.
[43] M. Rubin,et al. TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion , 2006, The American journal of surgical pathology.
[44] S. Murakami,et al. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[45] N. Tommerup,et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 , 1994, Cell.
[46] C. Hagel,et al. Expression of SOX9 and SOX10 in Central Neuroepithelial Tumor , 2006, Journal of Neuro-Oncology.
[47] Swneke D. Bailey,et al. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus , 2012, Genome research.
[48] N. Palanisamy,et al. Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4. , 2011, Cancer research.
[49] M. Rubin,et al. α‐Methylacyl‐CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow‐up Study , 2012, The Prostate.
[50] Zhaohui S. Qin,et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.